Journal: ACS pharmacology & translational science
Article Title: Covalent Modification of p53 by ( E )-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one.
doi: 10.1021/acsptsci.4c00447
Figure Lengend Snippet: Figure 1. NSC59984 reacts with free thiols via a Michael addition to the α-carbon. (A) Chemical structures of p53-reactivating molecules (NSC59984 and 1), MESNA (Sodium 2-mercaptoethanesulfonate (2)), adduct of Glutathione with NSC59984 (3), adduct of N-acetylcysteine with NSC59984 (4), and adduct of MESNA with NSC59984 (5). Potential sites for nucleophilic attack are labeled as α and β on the NSC59984 structure. The * label in 3, 4, and 5 represents the formation of a new stereogenic center after nucleophilic attack at the α carbon of NSC59984. Molecules 3 and 4 are a mixture of diastereomers, and 5 is a mixture of enantiomers. (B) Proposed scheme describing the reaction between 1 and 2. The * label represents the formation of a new stereogenic center after nucleophilic attack at the α carbon of 1. (C) 1H NMR analysis of time- dependent reaction of model compounds 1 and 2, showing thiol modification. Amplitude was adjusted to reduce signal-to-noise ratio in the stack plot so that specific peaks are more visible. (D) Quantum mechanical calculations of the LUMO for 1 (upper) or NSC59984 (lower) explain the pattern of reactivity.
Article Snippet: TP53 antibody (D01) (Santa Cruz) was diluted 1:50 before incubation, and a secondary antimouse AF647 antibody was used at 5 μg/mL before counter-staining.
Techniques: Labeling, Modification